Clinical Trial Update: A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing intravenously infused ABBV-400 to oral trifluridine/tipiracil (LONSURF) plus intravenous bevacizumab in adults with c-Me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ABBV-400
• Bevacizumab (bevacizumab)
• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: AbbVie | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: RECRUITING